At a glance
ClinicalIndex Comparison RecordN/ACompleted· 350 enrolled
Drug / intervention
Blood samples +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vasculopathy, Inflammation and Systemic Sclerosis: The Role of Endothelial Cell Activation and OX40/OX40L in Modulation of T Lymphocyte Activation
In Brief
A clinical study evaluating Blood samples and Biopsy for Systemic Sclerosis. Completed, enrolled 350 participants across 1 site.
Detailed Summary
It is a study of basic research with mechanistically objectives and including clinical biological samples.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Sclerosis
CountriesFrance
CollaboratorsSociete Francaise de Rhumatologie
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedSep 2015
Primary CompletionDec 2016
TodayJul 2026
First PostedSep 29, 2015
Enrollment StartMar 1, 2012
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 10.8 years ago
Interventions
Blood samplesbiological
* biological features of the standard follow-up * 2 more blood tube for the biological collection (serum and PBMC)
Biopsybiological
Skin biopsies